The OPTIMAL medication guideline and conversion calculator will help non-specialist professionals to better manage people with Parkinson’s when admitted to hospital.
News for professionals
Pimavanserin has been approved by the Food and Drug Administration for the treatment of hallucinations and delusions experienced in Parkinson's
Following reports that the needs of people with Lewy body dementia are not adequately recognised, the UK Parkinson's Excellence Network is calling for better awareness.
Professionals must be proactive in ensuring people with Parkinson's get support, after research shows that fear of sharing their condition means people can miss out.
The Royal Pharmaceutical Society is updating the single prescribing competency framework and is inviting consultation on the draft. They need your views.
A letter signed by senior Parkinson’s clinicians has forced the Scottish Government to commit to establishing a Scottish centre for DBS in Glasgow by autumn 2016.
In this guest blog, Alistair Stuart from uMotif talks about how you can get involved in groundbreaking research to deepen our understanding of Parkinson’s.